TipRanks
Go Ultimate55% OFF

MapLight Therapeutics, Inc. (MPLT) Income Statement

MapLight Therapeutics, Inc. Income Statement

Last quarter (Q2 2026), MapLight Therapeutics, Inc.'s total revenue was $0.00. In Q2, MapLight Therapeutics, Inc.'s net income was $-60.19M. See MapLight Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22
$ 0.00$ 0.00$ 0.00$ 0.00
$ -578.00K$ -701.00K$ -556.00K$ -574.00K
$ 168.50M$ 82.25M$ 56.73M$ 30.67M
Depreciation and Amortization$ 578.00K$ 701.00K$ 556.00K$ 574.00K
$ -160.57M$ -76.88M$ -55.15M$ -29.44M
$ -169.08M$ -82.95M$ -57.28M$ -31.25M
$ 7.93M$ 5.37M$ 1.57M$ 1.23M
$ -161.15M$ -77.58M$ -55.71M$ -30.02M
$ -161.15M$ -77.58M$ -55.71M$ -30.02M
Per Share Metrics
Basic EPS$ -3.66$ -1.87$ -1.34$ -0.72
Diluted EPS$ -3.66$ -1.87$ -1.34$ -0.72
Weighted Average Shares Outstanding44.02M41.43M41.43M41.43M
Weighted Average Shares Outstanding (Diluted)44.02M41.43M41.43M41.43M

Currency in USD

MapLight Therapeutics, Inc. Earnings and Revenue History

-180M-120M-60M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2022202320242025RevenueEarningsProfit Margin